Toggle Main Menu Toggle Search

Open Access padlockePrints

A platelet protein biochip rapidly detects an Alzheimer’s disease-specific phenotype

Lookup NU author(s): Professor Johannes Attems

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2014, The Author(s). Alzheimer’s disease (AD), a multifactorial neurodegenerative condition caused by genetic and environmental factors, is diagnosed using neuropsychological tests and brain imaging; molecular diagnostics are not routinely applied. Studies have identified AD-specific cerebrospinal fluid (CSF) biomarkers but sample collection requires invasive lumbar puncture. To identify AD-modulated proteins in easily accessible blood platelets, which share biochemical signatures with neurons, we compared platelet lysates from 62 AD, 24 amnestic mild cognitive impairment (aMCI), 13 vascular dementia (VaD), and 12 Parkinson’s disease (PD) patients with those of 112 matched controls by fluorescence two-dimensional differential gel electrophoresis in independent discovery and verification sets. The optimal sum score of four mass spectrometry (MS)-identified proteins yielded a sensitivity of 94 % and a specificity of 89 % (AUC = 0.969, 95 % CI = 0.944–0.994) to differentiate AD patients from healthy controls. To bridge the gap between bench and bedside, we developed a high-throughput multiplex protein biochip with great potential for routine AD screening. For convenience and speed of application, this array combines loading control-assisted protein quantification of monoamine oxidase B and tropomyosin 1 with protein-based genotyping for single nucleotide polymorphisms (SNPs) in the apolipoprotein E and glutathione S-transferase omega 1 genes. Based on minimally invasive blood drawing, this innovative protein biochip enables identification of AD patients with an accuracy of 92 % in a single analytical step in less than 4 h.


Publication metadata

Author(s): Veitinger M, Oehler R, Umlauf E, Baumgartner R, Schmidt G, Gerner C, Babeluk R, Attems J, Mitulovic G, Rappold E, Lamont J, Zellner M

Publication type: Article

Publication status: Published

Journal: Acta Neuropathologica

Year: 2014

Volume: 128

Issue: 5

Pages: 665-677

Print publication date: 01/11/2014

Online publication date: 24/09/2014

Acceptance date: 02/09/2014

Date deposited: 09/11/2017

ISSN (print): 0001-6322

ISSN (electronic): 1432-0533

Publisher: Springer Verlag

URL: https://doi.org/10.1007/s00401-014-1341-8

DOI: 10.1007/s00401-014-1341-8

PubMed id: 25248508


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
FP7-PEOPLE-2011-IAPP-286337
MTKICT-2005-029946

Share